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Several exonic and intronic mutations in the tau gene
have recently been identified in over a dozen families
Arnold Pick provided the first clinical description of fron-
with FTDP-17 (Figure 1). The known exonic mutations
totemporal dementia in 1892, and since then this class
are missense mutations located in the microtubule-
of disease has been shown to account for a significant
binding repeat region or close to it (Figure 1a), whereas
proportion of dementias. In 1911, Alois Alzheimer de-
the intronic mutations are located close to the splice-
scribed the neuropathological lesions characteristic of
donor site of the intron following exon 10, where they
Pick's disease. These so-called Pick bodies contain ab-
destabilize a predicted RNA stem-loop (Figure 1b) (Hut-
normal filaments, which consist of hyperphosphorylated
ton et al., 1998; Poorkaj et al., 1998; Spillantini et al., 1998b).
microtubule-associated protein tau. They resemble the
Exonic mutations in exons 9 (G272V), 12 (V337M), and 13
neurofibrillary lesions described by Alzheimer in 1907
(R406W) affect all six tau isoforms, whereas a mutation
in the disease subsequently named after him. Unlike
located in exon 10 (P301L) only affects tau isoforms
Alzheimer's disease, Pick's disease lacks significant amy-
with four repeats. Recombinant tau proteins with these
loid Ab pathology.
missense mutations show a reduced ability to promote
Frontotemporal dementias occur in familial forms and
microtubule assembly, which is more marked for three-
more commonly as sporadic cases. Neuropathologi-
repeat than for four-repeat isoforms (Hasegawa et al.,
cally, they are characterized by a remarkably circum-
1998). The likely primary effect of the exonic mutations
scribed atrophy of the frontal and temporal lobes of
is thus a reduced ability of mutated tau to interact with
the cerebral cortex, often with additional, subcortical
microtubules. The consequences of a reduced ability to
changes. In 1994, an autosomal-dominantly inherited
interact with microtubules may be equivalent to a partial
familial form of frontotemporal dementia with Parkinson-
loss of function, with resultant microtubule destabiliza-
ism was linked to chromosome 17q21.2, the same region
tion and deleterious effects on cellular processes such
that contains the tau gene (Wilhelmsen et al., 1994). This
was followed by the identification of other familial forms
of frontotemporal dementia that are linked to this region,
resulting in the denomination frontotemporal dementia
and Parkinsonism linked to chromosome 17 (FTDP-17)
for this class of disease. A major neuropathological char-
acteristic of FTDP-17 is a filamentous pathology made
of hyperphosphorylated tau protein (Spillantini et al.,
1998a). Tau filaments are space-occupying lesions that
may interfere with a host of cellular processes, leading
to the degeneration of affected nerve cells and glial
cells. Genetic linkage and neuropathology thus made
the tau gene a strong candidate gene for FTDP-17. Re-
cent work has now shown that the FTDP-17 locus is
Figure 1. Mutations in the Tau Gene in Frontotemporal Dementiaindeed the tau gene (Hutton et al., 1998; Poorkaj et al.,
and Parkinsonism Linked to Chromosome 17 (FTDP-17)1998; Spillantini et al., 1998b; reviewed by Hardy et al.,
(a) Schematic diagram of the six tau isoforms (A±F) that are ex-1998). The speed with which mutations are being discov-
pressed in adult human brain. Alternatively spliced exons are shown
ered suggests that a defective tau gene is a major cause in red (exon 2), green (exon 3), and yellow (exon 10), and black bars
of inherited dementing disease. indicate the microtubule-binding repeats. Four missense mutations
Tau Mutations in FTDP-17 in the coding region are shown. They affect all six tau isoforms, with
the exception of P301L, which only affects tau isoforms with fourIn adult human brain, six tau isoforms are produced
microtubule-binding repeats. Amino acid numbering correspondsfrom a single gene by alternative mRNA splicing (Figure
to the 441-amino-acid isoform of human brain tau.1a, A±F) (Goedert et al., 1996). They differ from each
(b) Predicted stem-loop in the pre-mRNA at the 39 end of exon 10.
The likely destabilizing effects of the four intronic mutations are
indicated using one possible representation of the stem-loop. Exon




Table 1. Tau Mutations, Isoforms, and Filaments in FTDP-17
Tau Mutation Soluble Tau Filamentous Tau Tau Filaments
P301L (exon 10) Normal ratio of 4-repeat isoforms; Narrow, twisted
3- to 4-repeat isoforms small amount of ribbons; rope-like
(4-repeat isoforms 3-repeat isoform filaments
mutated)
Intron following exon 10 Abnormal preponderance 4-repeat isoforms Wide, twisted
of 4- over 3-repeat ribbons
isoforms
V337M (exon 12) Normal ratio of 3- to All 6 isoforms Paired helical
4-repeat isoforms filaments; straight
(all isoforms mutated) filaments
Based on Hutton et al. (1998), Poorkaj et al. (1998), and Spillantini et al. (1996, 1997, 1998b, 1998c).
as fast axonal transport. Alternatively, the primary con- The different kinds of filament have all been shown to
contain tau by labeling with various anti-tau antibodies.sequence may be a gain of toxic function with excess
free tau available for assembly into filaments. The net In the case of Dutch family 1, there is a P301L mutation
in exon 10, and the tau deposits are characterized byeffect of the intronic mutations is increased splicing in
of exon 10, leading to a change in the ratio of three- narrow, twisted, ribbon-like filaments (Figure 2A); these
filaments consist predominantly of four-repeat tau iso-repeat to four-repeat tau isoforms (Hutton et al., 1998;
Spillantini et al., 1998a, 1998b). Earlier work had sug- forms, with a small amount of the most abundant three-
repeat isoform (Hutton et al., 1998; Spillantini et al.,gested that three-repeat and four-repeat tau isoforms
may bind to different sites on microtubules (Goode and 1998c). A minor fraction of the filaments are rope-like, a
morphology that is also seen occasionally in Alzheimer'sFeinstein, 1994). Overproduction of tau isoforms with
four repeats may result in an excess of tau over available disease (Figure 2B). The tau pathology is both neuronal
and glial. In familial multiple system tauopathy with pre-binding sites on microtubules, thus creating a gain of
toxic function similar to that of the missense mutations, senile dementia (MSTD), there is a G to A transition at
the nucleotide adjacent to the splice-donor site of thewith unbound excess tau available for assembly into
filaments. intron following exon 10. The tau deposits in familial
MSTD are characterized by wide, twisted, ribbon-likeTau Filaments in FTDP-17
The morphological and biochemical characteristics of filaments (Figure 2C), which consist exclusively of four-
repeat tau isoforms (Spillantini et al., 1997, 1998b). Theisolated tau filaments have been studied in cases of
FTDP-17 with mutations in exons 10 and 12, as well as tau pathology is both neuronal and glial. The dimensions
of the narrow (Dutch family 1) and wide (familial MSTD)in cases with intronic mutations (Table 1 and Figure 2).
twisted ribbons are such that the wide ribbons could
be formed by two copies of the narrow ribbons joined
across the central axis (Figure 2C).
In comparison to Dutch family 1 and familial MSTD,
where exonic and intronic mutations affect predomi-
nantly 4-repeat tau isoforms, there are also several iden-
tified families with mutations in other exons that affect
all six isoforms. Seattle family A has a V337M mutation
in exon 12 and is characterized by paired helical and
straight filaments (Figures 2D and 2E), which consist of
all six tau isoforms (Spillantini et al., 1996; Poorkaj et
al., 1998). The tau pathology is largely neuronal. Iowa
family has a R406W mutation in exon 13 and is also
characterized by a neuronal tau pathology with paired
helical filaments (Reed et al., 1997; Hutton et al., 1998).
These findings contrast with filaments from Pick bodies
that only contain three-repeat tau isoforms (Delacourte
and BueÂ e, 1997). So far, there have been no reports of
mutations that lead to the formation of tau filaments
consisting predominantly of three-repeat isoforms.Figure 2. Tau Filaments in FTDP-17
The emerging picture is that of a remarkably directDutch family 1 is characterized by the presence of narrow twisted
correspondence between the locations of tau muta-ribbons (A) and occasional rope-like filaments (B). The tau pathology
is both neuronal and glial. Familial multiple system tauopathy with tions, the cellular pathology, and the isoform composi-
presenile dementia is characterized by wide twisted ribbons (C), tions and morphologies of tau filaments (Table 1). Muta-
which may be formed by two copies of the narrow twisted ribbons tions in exon 10 itself or in the intron following exon 10
joined across the central axis. The tau pathology is both neuronal
lead to a neuronal and glial tau pathology, with theand glial. Seattle family A is characterized by the presence of paired
twisted ribbon-like filaments being made predominantlyhelical (D) and straight (E) filaments. The tau pathology is largely
neuronal. Scale bar, 100 nm. or exclusively of four-repeat tau isoforms. The glial tau
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pathology is more severe in cases with intronic muta- al., 1996). At present, there is no experimental evidence
linking hyperphosphorylation of tau to filament assem-tions than in cases with a mutation in exon 10. Missense
mutations located outside exon 10 appear to lead to a bly, and it is unclear whether hyperphosphorylation is
either necessary or sufficient for assembly. Thus, as-mostly neuronal pathology, with the paired helical and
straight filaments being made of all six tau isoforms. sembly of full-length hyperphosphorylated recombinant
tau into filaments has not been observed. In fact, experi-It is unclear why some mutations lead to a neuronal
and glial tau pathology, whereas others result in a largely mental studies in vitro have shown that interactions be-
tween tau and negatively charged sugar polymers, suchneuronal pathology. In normal human brain, tau protein
is mostly confined to nerve cells, where it is concen- as sulphated glycosaminoglycans and RNA, lead to
rapid assembly into twisted and straight filaments in atrated in axons. Although it is not known which isoforms
account for the low levels of tau in glial cells, the cellular phosphorylation-independent manner (Goedert et al.,
1996; Kampers et al., 1996; PeÂ rez et al., 1996). Moreover,pathology of FTDP-17 is compatible with nerve cells
expressing all six tau isoforms and glial cells expressing heparan sulphate staining of nerve cells in the early
stages of neurofibrillary pathology has been describedpredominantly four-repeat isoforms. In the case of muta-
tions located outside exon 10, the ordered assembly of (Goedert et al., 1996; Spillantini et al., 1997, 1998c).
These studies have provided a first robust method fortau into filaments may be driven by three-repeat iso-
forms, leading to the formation of paired helical and the assembly of synthetic filaments from full-length tau
protein.straight filaments in nerve cells. Four-repeat tau iso-
forms drive filament assembly when tau mutations are However, the mechanisms that lead to assembly of
tau into filaments in brain remain to be discovered. It islocated in exon 10 or in the intron following exon 10,
resulting in the formation of twisted ribbon-like filaments possible that a reduced ability to interact with microtu-
bules, which could have several different causes, is ain both nerve cells and glial cells.
The study of familial MSTD has shown that a mutation necessary first step for filament assembly. Assembly is
probably an energetically unfavorable, nucleation-depen-located close to the splice-donor site of the intron fol-
lowing exon 10 is sufficient to lead to a tau pathology dent process that requires a critical concentration of
tau (Goedert et al., 1996). Many cells may have levelsreminiscent of progressive supranuclear palsy (PSP)
and corticobasal degeneration (CBD), two largely spo- of tau below the critical concentration; other cells may
have effective mechanisms for preventing the formationradic tauopathies (Delacourte and BueÂ e, 1997; Spil-
lantini et al., 1997, 1998b). Like familial MSTD, PSP and of tau nuclei or may be able to degrade them once they
have formed. Insufficient protective mechanisms mayCBD are characterized by a neuronal and glial tau pa-
thology, with the filaments consisting of four-repeat tau underlie the selective degeneration of nerve cells and
glial cells, which is especially striking in FTDP-17, withisoforms (Delacourte and BueÂ e, 1997). Intriguingly, a
polymorphism in the intron preceding exon 10 has been the characteristic, sometimes unilateral, razor-sharp de-
marcations between affected and unaffected areas inshown to be a risk factor for PSP in Caucasians (Conrad
et al., 1997). cerebral cortex.
The precise significance of the different filament mor-Pathogenesis of FTDP-17
The pathway leading from a mutation in the tau gene to phologies observed in the various tauopathies is not
clear. It is known that the repeat region of tau forms theneurodegeneration is unknown. A partial loss of function
of tau resulting from the mutations could lead to the densely packed core of the paired helical and straight
filaments, with the amino- and carboxy-terminal partsdestabilization of microtubules, with deleterious conse-
quences for cellular processes, such as rapid axonal of the molecule forming a proteolytically sensitive coat.
Also, for filaments assembled in vitro in the presencetransport. However, in the case of the intronic mutations,
where four-repeat tau is overproduced, this appears of sulphated glycosaminoglycans, the morphology of
the filaments depends on the number of repeats in theunlikely. Moreover, mutations in exon 10 will only affect
20%±25% of tau molecules, with 75%±80% of tau being tau isoform used (Goedert et al., 1996). Thus, mutations
in the repeat region or a change in relative amountsnormal.
It is possible, however, that a correct ratio of wild- of three- and four-repeat isoforms could well influence
filament morphology. Treatment of paired helical fila-type three-repeat to four-repeat tau is essential for the
normal function of tau in human brain. An alternative ments with acid leads to untwisted ribbon-like filaments
like those seen in familial MSTD, suggesting a closehypothesis is that a partial loss of function of tau is
necessary for setting in motion the mechanisms that similarity in packing of tau molecules in the various
structures (Crowther, 1991; Spillantini et al., 1997). Theultimately lead to filament assembly. Besides leading to
a partial loss of function phenotype, tau mutations may most important aspect may be the extended filamentous
nature of all the assemblies and the deleterious effecthave additional effects on phosphorylation and filament
assembly. that this has on intracellular processes, rather than the
detailed morphology of the different filaments.Where studied, pathological tau from FTDP-17 brain
is hyperphosphorylated (Spillantini et al., 1998a). As the Implications
A major implication deriving from the work on FTDP-17known mutations in tau do not create additional phos-
phorylation sites, hyperphosphorylation of tau must be is that a normal ratio of functional tau isoforms to binding
sites on microtubules appears to be essential for pre-an event downstream of the primary effects of the muta-
tions and may be a consequence of the partial loss of venting neurodegeneration. This finely tuned balance
may be very sensitive to disruption, in line with the factfunction. It probably reinforces the effects of the muta-
tions, since it is well established that hyperphosphory- that a large percentage of the general population devel-
ops limited filamentous tau pathology with aging (Braaklated tau is unable to bind to microtubules (Goedert et
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Kampers, T., Friedhoff, P., Biernat, J., Mandelkow, E.M., and Man-and Braak, 1997). The new work has firmly established
delkow, E. (1996). FEBS Lett. 399, 344±349.that the events leading to a filamentous tau pathology
PeÂ rez, M., Valpuesta, J.M., Medina, M., Montejo de Garcini, E., andor the mere presence of tau filaments are sufficient for
Avila, J. (1996). J. Neurochem. 67, 1183±1190.the degeneration of affected nerve cells and glial cells
Poorkaj, P., Bird, T.D., Wijsman, E., Nemens, E., Garruto, R.M., An-and the onset of dementia. This had long been sus-
derson, L., Andreadis, A., Wiederholt, W.C., Raskind, M., and Schel-
pected to be the case, largely because of the good lenberg, G.D. (1998). Ann. Neurol. 43, 815±825.
correlation between neurofibrillary lesions and nerve cell
Reed, L.A., Grabowski, T.J., Schmidt, M.L., Morris, J.C., Goate, A.,
degeneration in Alzheimer's disease. Solodkin, A., Van Hoesen, G.W., Schelper, R.L., Talbot, C.J., Wragg,
The recent findings in FTDP-17 may also shed light M.A., et al. (1997). Ann. Neurol. 42, 564±572.
on the mechanisms that lead to the filamentous tau Spillantini, M.G., Crowther, R.A., and Goedert, M. (1996). Acta Neuro-
pathology of Alzheimer's disease. Seattle family A has pathol. 92, 42±48.
shown that a V337M mutation in the third microtubule- Spillantini, M.G., Goedert, M., Crowther, R.A., Murrell, J.R., Farlow,
M.R., and Ghetti, B. (1997). Proc. Natl. Acad. Sci. USA 94, 4113±4118.binding domain is sufficient to lead to a tau pathology
that is indistinguishable from that of Alzheimer's disease Spillantini, M.G., Bird, T.D., and Ghetti, B. (1998a). Brain Pathol. 8,
387±402.in its ultrastructural and biochemical characteristics
Spillantini, M.G., Murrell, J.R., Goedert, M., Farlow, M.R., Klug, A.,(Spillantini et al., 1996; Poorkaj et al., 1998). As in Alzhei-
and Ghetti, B. (1998b). Proc. Natl. Acad. Sci. USA 95, 7737±7741.mer's disease, the tau filaments are paired helical and
Spillantini, M.G., Crowther, R.A., Kamphorst, W., Heutink, P., andstraight filaments that consist of all six tau isoforms
Van Swieten, J.C. (1998c). Am. J. Pathol. 153, 1359±1363.(Spillantini et al., 1996). The proportions of paired helical
St. George-Hyslop, P.H., Levesque, G., Levesque, I., Rommens, J.,(90%±95%) and straight (5%±10%) filaments in Seattle
Westaway, D., and Fraser, P.E. (1996). Cold Spring Harbor Symp.family A are also identical to those found in Alzheimer's
Quant. Biol. 61, 559±564.
disease. It suggests that in Alzheimer's disease a re-
Wilhelmsen, K.C., Lynch, T., Pavlou, E., Higgins, M., and Nygaard,
duced ability of tau to interact with microtubules may T.G. (1994). Am. J. Hum. Genet. 55, 1159±1165.
be upstream of hyperphosphorylation and filament as-
sembly. Unlike Alzheimer's disease, cases with FTDP-
17 have so far been found to lack significant Ab amyloid
pathology.
The existence of mutations in the amyloid precursor
protein (APP) gene in about 30 families with early-onset
Alzheimer's disease has revealed a genetic lesion that
leads to a filamentous tau pathology (Hardy et al., 1998),
as has the larger number of families with mutations in
the presenilin genes (St. George-Hyslop et al., 1996). In
these families, tau pathology must be downstream of
APP and presenilin malfunction, but it may be the tau
pathology that eventually causes neurodegeneration.
The various FTDP-17 families now show that primary
lesions in tau itself can lead to neurodegeneration. It
remains to be seen whether one can generalize from
these familial cases to the 20±25 million cases of spo-
radic Alzheimer's disease. The prevention of a filamen-
tous tau pathology is likely to be an effective therapeutic
approach, not only for Alzheimer's disease, but also for
the other tauopathies.
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